Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hyperthermia × Brachytherapy × Clear all

Phase

Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 16 Endometrial Neoplasms 4 Prostatic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Endometrial Clear Cell Adenocarcinoma 2 Vaginal Neoplasms 1 Uveitis 1 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Obesity 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Unknown Primary 1 Locally Advanced Cervical Cancer 1 Locally Advanced Cervical Adenocarcinoma 1 Liver Neoplasms 1 Hyperthermia 1 Head and Neck Neoplasms 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Directly Observed Therapy 1 Choroid Neoplasms 1 Carcinosarcoma 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Diathermy 3 Drug Therapy 2 Radiotherapy 1 Radiation 1 Mitomycin 1 Gemcitabine 1 Fluorouracil 1 Doxorubicin 1 Cytoreduction Surgical Procedures 1 Conization 1 Cisplatin 1 Capecitabine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03332069 2017-11-07

mEHT

University of Witwatersrand, South Africa

Phase 3 Unknown

Hyperthermia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡